Literature DB >> 9798029

Clonal relationships among high-level penicillin-resistant Streptococcus pneumoniae in the United States.

G V Doern1, A B Brueggemann, M Blocker, M Dunne, H P Holley, K S Kehl, J Duval, K Kugler, S Putnam, A Rauch, M A Pfaller.   

Abstract

During the past 6 to 7 years, the problem of antimicrobial resistance in Streptococcus pneumoniae has grown dramatically in the United States. Currently, approximately 26.5% of pneumococcal isolates express intermediate levels of resistance to penicillin; approximately 17.5% are highly penicillin resistant. We studied whether clonal relationships exist among current isolates of high-level penicillin-resistant S. pneumoniae (PRSP) in the United States. One hundred forty-seven PRSP isolates recovered in a 30-center surveillance study in the United States during 1994-1995 were characterized with respect to serotype, antimicrobial susceptibility pattern, and pulsed-field gel electrophoresis (PFGE) profile. Only six serotypes were observed among the 147 PRSP isolates examined in this study: 6A, 6B, 9A, 14, 19F, and 23F. One hundred three (70.1%) of the 147 strains were characterized by one of only nine PFGE types; 76 (51.7%) of the 147 isolates were characterized by only four PFGE profiles. Currently in the United States, most PRSP strains are represented by relatively few clonal groups.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9798029     DOI: 10.1086/514937

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  17 in total

1.  Relationship between capsular type, penicillin susceptibility, and virulence of human Streptococcus pneumoniae isolates in mice.

Authors:  E Azoulay-Dupuis; V Rieux; M Muffat-Joly; J P Bédos; E Vallée; C Rivier; R Isturiz; C Carbon; P Moine
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

2.  Managing upper respiratory tract infections: practice without evidence.

Authors:  E Lautenbach; J P Metlay
Journal:  J Gen Intern Med       Date:  1999-03       Impact factor: 5.128

3.  Clonal groups of penicillin-nonsusceptible Streptococcus pneumoniae in Baltimore, Maryland: a population-based, molecular epidemiologic study.

Authors:  M C McEllistrem; M Pass; J A Elliott; C G Whitney; L H Harrison
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

4.  Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.

Authors:  G V Doern; K P Heilmann; H K Huynh; P R Rhomberg; S L Coffman; A B Brueggemann
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

5.  Biographical Feature: Gary V. Doern, Ph.D.

Authors:  Betty A Forbes
Journal:  J Clin Microbiol       Date:  2015-08-26       Impact factor: 5.948

6.  Upgrading antibiotic use within a class: tradeoff between resistance and treatment success.

Authors:  Y Claire Wang; Marc Lipsitch
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-13       Impact factor: 11.205

7.  Comparison of results generated by serotyping, pulsed-field restriction analysis, ribotyping, and repetitive-sequence PCR used to characterize penicillin-resistant pneumococci from the United States.

Authors:  W M Dunne; K S Kehl; C A Holland-Staley; A B Brueggemann; M A Pfaller; G V Doern
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

8.  Genetic relatedness of levofloxacin-nonsusceptible Streptococcus pneumoniae isolates from North America.

Authors:  Crystal N Johnson; William H Benjamin Jr; Stephen A Moser; Susan K Hollingshead; Xiaotian Zheng; Marilyn J Crain; Moon H Nahm; Ken B Waites
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

9.  Novel penicillin-, cephalosporin-, and macrolide-resistant clones of Streptococcus pneumoniae serotypes 23F and 19F in Taiwan which differ from international epidemic clones.

Authors:  C C Chiou; M C McEllistrem
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

10.  Clinical isolates of Streptococcus pneumoniae with different susceptibilities to ceftriaxone and cefotaxime.

Authors:  James A Karlowsky; Mark E Jones; Deborah C Draghi; Daniel F Sahm
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.